Higher dietary potassium intake is associated with an increased risk of death in long-term hemodialysis (HD) patients, new findings suggest.

MUNICH, GERMANY—Planned early initiation of dialysis does not improve survival or clinical outcomes among patients with end-stage renal disease, study findings show.

MUNICH, GERMANY—Atorvastatin may benefit hemodialysis (HD) patients with type 2 diabetes and high LDL cholesterol levels, a researcher reported at the the European Renal Association-European Dialysis and Transplant Association 2010 Congress.

Weekly (50,000 units) and monthly doses (50,000 units) of ergocalciferol treatment does not significantly impact markers of mineral metabolism (MM) in chronic hemodialysis (HD) patients, a study suggests.

The Redsense safety device, which is designed to detect venous needle displacement during hemodialysis (HD), has received FDA approval for home/self use during home HD, according to the device's manufacturer, Redsense Medical.

Cinacalcet plus low-dose vitamin D for secondary hyperparathyroidism yielded encouraging results

Central venous catheters (CVCs) are the most prevalent vascular access type in patients who initiate hemodialysis (HD) following a failed renal transplant, a study found.

Supplementation could provide a low-cost way to protect against cardiovascular events.

NEW YORK—In men at high risk of cardiovascular events, left ventricular mass index (LVMI) may help better predict renal outcomes, including the need for hemodialysis (HD), researchers reported here at the American Society of Hypertension 25th Annual Scientific Meeting and Exposition.

SEATTLE—Guidelines recommend that hemodialysis (HD) patients have predialysis BP levels below 140/90 mm Hg, but study findings suggest that such levels may increase their risk of death, according to David Goodkin, MD, an investigator with Arbor Research Collaborative for Health.